Loss of fibulin-5 binding to β1 integrins inhibits tumor growth by increasing the level of ROS

DMM Disease Models and Mechanisms

Volumn 3, Issue 5-6, 2010, Pages 333-342

  Schluterman, Marie K ^a   Chapman, Shelby L ^b   Korpanty, Grzegorz ^a   Ozumi, Kiyoshi ^c   Fukai, Tohru ^c   Yanagisawa, Hiromi ^b   Brekken, Rolf A ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ARGINYLGLYCYLASPARTIC ACID; BETA1 INTEGRIN; FIBRONECTIN; FIBULIN 5; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA DAMAGE; ENDOTHELIUM CELL; FIBROBLAST; METASTASIS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PANCREAS CARCINOMA; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TUMOR VASCULARIZATION; WILD TYPE;

ANIMALS; ANTIGENS, CD29; ANTIOXIDANTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; EMBRYO, MAMMALIAN; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FIBROBLASTS; FIBRONECTINS; MICE; NEOVASCULARIZATION, PATHOLOGIC; OXIDATIVE STRESS; PANCREATIC NEOPLASMS; PROTEIN BINDING; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS;

ANIMALIA; MUS;

EID: 77952207386     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.003707     Document Type: Article

References (43)

1. Albig, A. R. and Schiemann, W. P. (2004). Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. DNA Cell Biol. 23, 367-379. (Pubitemid 38850384)
2. Albig, A. R. and Schiemann, W. P. (2005). Fibulin-5 function during tumorigenesis. Future Oncol. 1, 23-35.
3. Albig, A. R., Neil, J. R. and Schiemann, W. P. (2006). Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res. 66, 2621-2629.
4. Arnold, S. A., Mira, E., Muneer, S., Korpanty, G., Beck, A. W., Holloway, S. E., Manes, S. and Brekken, R. A. (2008). Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC. Exp. Biol. Med. (Maywood) 233, 860-873.
5. Bonomini, F., Tengattini, S., Fabiano, A., Bianchi, R. and Rezzani, R. (2008). Atherosclerosis and oxidative stress. Histol. Histopathol. 23, 381-390.
6. Brekken, R. A., Puolakkainen, P., Graves, D. C., Workman, G., Lubkin, S. R. and Sage, E. H. (2003). Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. J. Clin. Invest. 111, 487-495. (Pubitemid 36228006)
7. Chiarugi, P., Pani, G., Giannoni, E., Taddei, L., Colavitti, R., Raugei, G., Symons, M., Borrello, S., Galeotti, T. and Ramponi, G. (2003). Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J. Cell Biol. 161, 933-944. (Pubitemid 36718426)
8. Das, U. (2002). A radical approach to cancer. Med. Sci. Monit. 8, RA79-RA92.
9. Engel, R. H. and Evens, A. M. (2006). Oxidative stress and apoptosis: a new treatment paradigm in cancer. Front. Biosci. 11, 300-312.
10. Fang, J., Nakamura, H. and Iyer, A. K. (2007). Tumor-targeted induction of oxystress for cancer therapy. J. Drug Target. 15, 475-486. (Pubitemid 47213870)
11. Farrow, B., Albo, D. and Berger, D. H. (2008). The role of the tumor microenvironment in the progression of pancreatic cancer. J. Surg. Res. 149, 319-328.
12. Hallmann, R., Mayer, D. N., Berg, E. L., Broermann, R. and Butcher, E. C. (1995). Novel mouse endothelial cell surface marker is suppressed during differentiation of the blood brain barrier. Dev. Dyn. 202, 325-332.
13. Hsieh, Y. H., Juliana, M. M., Hicks, P. H., Feng, G., Elmets, C., Liaw, L. and Chang, P. L. (2006). Papilloma development is delayed in osteopontin-null mice: implicating an antiapoptosis role for osteopontin. Cancer Res. 66, 7119-7127. (Pubitemid 44197689)
14. Kowal, R. C., Richardson, J. A., Miano, J. M. and Olson, E. N. (1999). EVEC, a novel epidermal growth factor-like repeat-containing protein upregulated in embryonic and diseased adult vasculature. Circ. Res. 84, 1166-1176.
15. Kuang, P. P., Goldstein, R. H., Liu, Y., Rishikof, D. C., Jean, J. C. and Joyce-Brady, M. (2003). Coordinate expression of fibulin-5/DANCE and elastin during lung injury repair. Am. J. Physiol. Lung Cell Mol. Physiol. 285, L1147-L1152. (Pubitemid 37310104)
16. Kunz-Schughart, L. A. and Knuechel, R. (2002). Tumor-associated fibroblasts (part II): functional impact on tumor tissue. Histol. Histopathol. 17, 623-637.
17. Lawler, J. and Detmar, M. (2004). Tumor progression: the effects of thrombospondin-1 and -2. Int. J. Biochem. Cell Biol. 36, 1038-1045.
18. Li, H., Fan, X. and Houghton, J. (2007). Tumor microenvironment: the role of the tumor stroma in cancer. J. Cell Biochem. 101, 805-815. (Pubitemid 47040863)
19. Liu, X., Zhao, Y., Gao, J., Pawlyk, B., Starcher, B., Spencer, J. A., Yanagisawa, H., Zuo, J. and Li, T. (2004). Elastic fiber homeostasis requires lysyl oxidase-like 1 protein. Nat. Genet. 36, 178-182. (Pubitemid 38174378)
20. Lomas, A. C., Mellody, K. T., Freeman, L. J., Bax, D. V., Shuttleworth, C. A. and Kielty, C. M. (2007). Fibulin-5 binds human smooth-muscle cells through alpha5beta1 and alpha4beta1 integrins, but does not support receptor activation. Biochem. J. 405, 417-428.
21. Lotery, A. J., Baas, D., Ridley, C., Jones, R. P., Klaver, C. C., Stone, E., Nakamura, T., Luff, A., Griffiths, H., Wang, T. et al. (2006). Reduced secretion of fibulin 5 in agerelated macular degeneration and cutis laxa. Hum. Mutat. 27, 568-574. (Pubitemid 43865730)
22. Mantovani, A., Allavena, P., Sica, A. and Balkwill, F. (2008). Cancer-related inflammation. Nature 454, 436-444.
23. Marikovsky, M. (2002). Thiram inhibits angiogenesis and slows the development of experimental tumours in mice. Br. J. Cancer 86, 779-787.
24. Nakamura, T., Ruiz-Lozano, P., Lindner, V., Yabe, D., Taniwaki, M., Furukawa, Y., Kobuke, K., Tashiro, K., Lu, Z., Andon, N. L. et al. (1999). DANCE, a novel secreted RGD protein expressed in developing, atherosclerotic, and balloon-injured arteries. J. Biol. Chem. 274, 22476-22483. (Pubitemid 129529263)
25. Nguyen, A. D., Itoh, S., Jeney, V., Yanagisawa, H., Fujimoto, M., Ushio-Fukai, M. and Fukai, T. (2004). Fibulin-5 is a novel binding protein for extracellular superoxide dismutase. Circ. Res. 95, 1067-1074. (Pubitemid 39557893)
26. Pietras, K., Pahler, J., Bergers, G. and Hanahan, D. (2008). Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting. PLoS Med. 5, e19. (Pubitemid 351198267)
27. Pozzi, A., Moberg, P. E., Miles, L. A., Wagner, S., Soloway, P. and Gardner, H. A. (2000). Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization. Proc. Natl. Acad. Sci. USA 97, 2202-2207. (Pubitemid 30134046)
28. Proia, D. A. and Kuperwasser, C. (2005). Stroma: tumor agonist or antagonist. Cell Cycle 4, 1022-1025.
29. Puolakkainen, P. A., Brekken, R. A., Muneer, S. and Sage, E. H. (2004). Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis. Mol. Cancer Res. 2, 215-224. (Pubitemid 39031082)
30. Sheibani, N. and Frazier, W. A. (1998). Down-regulation of platelet endothelial cell adhesion molecule-1 results in thrombospondin-1 expression and concerted regulation of endothelial cell phenotype. Mol. Biol. Cell 9, 701-713. (Pubitemid 28173627)
31. Spencer, J. A., Hacker, S. L., Davis, E. C., Mecham, R. P., Knutsen, R. H., Li, D. Y., Gerard, R. D., Richardson, J. A., Olson, E. N. and Yanagisawa, H. (2005). Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration. Proc. Natl. Acad. Sci. USA 102, 2946-2951.
32. Sullivan, K. M., Bissonnette, R., Yanagisawa, H., Hussain, S. N. and Davis, E. C. (2007). Fibulin-5 functions as an endogenous angiogenesis inhibitor. Lab. Invest. 87, 818-827. (Pubitemid 47077259)
33. Takahashi, A., Masuda, A., Sun, M., Centonze, V. E. and Herman, B. (2004). Oxidative stress-induced apoptosis is associated with alterations in mitochondrial caspase activity and Bcl-2-dependent alterations in mitochondrial pH (pHm). Brain Res. Bull. 62, 497-504. (Pubitemid 38253035)
34. Tanaka, T., Halicka, H. D., Huang, X., Traganos, F. and Darzynkiewicz, Z. (2006). Constitutive histone H2AX phosphorylation and ATM activation, the reporters of DNA damage by endogenous oxidants. Cell Cycle 5, 1940-1945. (Pubitemid 44435299)
35. Timpl, R., Sasaki, T., Kostka, G. and Chu, M. L. (2003). Fibulins: a versatile family of extracellular matrix proteins. Nat. Rev. Mol. Cell Biol. 4, 479-489. (Pubitemid 36648593)
36. Touyz, R. M. and Schiffrin, E. L. (2004). Reactive oxygen species in vascular biology: implications in hypertension. Histochem. Cell Biol. 122, 339-352.
37. Ushio-Fukai, M. and Alexander, R. W. (2004). Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol. Cell Biochem. 264, 85-97. (Pubitemid 39366107)
38. Valavanidis, A., Vlachogianni, T. and Fiotakis, C. (2009). 8-hydroxy-2′ -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 27, 120-139.
39. Wu, W. S. (2006). The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 25, 695-705.
40. Yanagisawa, H., Davis, E. C., Starcher, B. C., Ouchi, T., Yanagisawa, M., Richardson, J. A. and Olson, E. N. (2002). Fibulin-5 is an elastin-binding protein essential for elastic fibre development in vivo. Nature 415, 168-171. (Pubitemid 34059517)
41. Yang, Z., Mu, Z., Dabovic, B., Jurukovski, V., Yu, D., Sung, J., Xiong, X. and Munger, J. S. (2007). Absence of integrin-mediated TGFbeta1 activation in vivo recapitulates the phenotype of TGFbeta1-null mice. J. Cell Biol. 176, 787-793. (Pubitemid 46425539)
42. Yue, W., Sun, Q., Landreneau, R., Wu, C., Siegfried, J. M., Yu, J. and Zhang, L. (2009). Fibulin-5 suppresses lung cancer invasion by inhibiting matrix metalloproteinase-7 expression. Cancer Res. 69, 6339-6346.
43. Zheng, Q., Davis, E. C., Richardson, J. A., Starcher, B. C., Li, T., Gerard, R. D. and Yanagisawa, H. (2007). Molecular analysis of fibulin-5 function during de novo synthesis of elastic fibers. Mol. Cell. Biol. 27, 1083-1095. (Pubitemid 46174569)